Coloplast's bottom line disappoints in otherwise strong report
Despite increasing revenues, Coloplast has still managed to take a step back on its profit in Q1’22/23.
by marketwire, translated by daniel pedersen
Coloplast came out of the first quarter of fiscal 2022/2023 better than analysts had thought, though the Danish medtech company’s bottom line read less than expected.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
